HEALTH-RELATED QUALITY OF LIFE, FUNCTIONING, AND SYMPTOMS WITH ODRONEXTAMAB MONOTHERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA BY POD24 STATUS IN THE ELM-2 STUDY